Capital Markets | Healthcare & Life Sciences
Just Closed
The MedProperties Medical Office Portfolio Recapitalization:
A 23-Property Medical Office Portfolio totaling over 1 million square feet across 12 states
Transaction Highlights
Date Closed 01/14/2022
Size 1,006,029 SF
Occupancy 94%
Location 12 States (TX, CA, MO, IN, OH, KY, TN, WV, NY, PA, NC, FL)
MedProperties Medical Office Portfolio Recapitalization
CBRE U.S. Healthcare and Life Sciences Capital Markets is pleased to announce the closing of the MedProperties Medical Office Portfolio (the “Portfolio” or alternatively the “Properties”), which included over 1 million square feet of healthcare real estate assets located across 12 states. Lee Asher, Chris Bodnar, Jordan Selbiger, Ryan Lindsley, Sabrina Solomiany and Zack Holderman acted as MedProperties’ exclusive advisors.
Dallas-based MedProperties Realty Advisors is a real estate private equity firm exclusively focused on investments in healthcare real estate. The firm has acquired or developed over 4 million square feet across 24 states. MedProperties closed the recapitalization transaction with Kayne Anderson Real Estate and Remedy Medical Properties through a joint venture in which MedProperties retained a minority equity position, and continues to act as the asset manager on behalf of the new joint venture. The Portfolio is 94% leased and includes a roster of high caliber tenants including 71% leased to leading hospitals, health systems and investment grade tenants.
For more information, or if we can help with your healthcare real estate holdings, please contact us.
For more information, please contact:
Lee Asher
Vice Chairman
+1 404 504 5965
Chris Bodnar
Vice Chairman
+1 303 628 1711
Jordan Selbiger
Senior Director
+1 404 923 1259
Ryan Lindsley
Senior Director
+1 303 628 1745
Sabrina Solomiany
First Vice President
+1 404 536 5054
Zack Holderman
Senior Vice President
+1 858 546 4670
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
